Gastrointestinal Cancer News

Treatment for anal cancer has advanced significantly over the years, but the standard radiotherapy regimen used regardless of tumor size has led to various immediate and long-term adverse events.

Long-term survivors of certain early-stage cancers diagnosed after age 65 years appeared at higher risk for mortality due to noncancer causes, according to study results published in JAMA Network Open.

Proteins and genetic material secreted by fatty liver cells stimulate the spread of colorectal cancer to the liver, study results published in Cell Metabolism showed.

Leaders of the oncology community expressed mixed reaction to International Agency for Research on Cancer’s declaration of aspartame as possibly carcinogenic to humans.

Research demonstrated that hepatocellular carcinoma surveillance is cost-effective at a lower incidence threshold of 0.7% in virologically cured patients with hepatitis C virus, underscoring the need to update clinical guidelines.

Falls in an inpatient cancer rehabilitation unit occurred less frequently than previous studies have estimated and usually caused patients no harm, according to data published in JCO Oncology Practice.

Women receiving cancer treatment in clinical trials exhibited higher risk for severe symptomatic and hematologic adverse events than their male counterparts, according to a study.

The FDA announced several regulatory actions the past few weeks.

The combination of durvalumab and tremelimumab-actl conferred a sustained OS benefit at 4 years among patients with unresectable hepatocellular carcinoma, according to phase 3 trial results from the agents’ manufacturer.

People living with HIV and various cancer types may be safely treated with immune checkpoint inhibitors, according to results of a retrospective study published in Journal of Clinical Oncology.